Russia Over-the-counter (OTC) Drugs Industry Outlook to 2017- Driven by Rising Ageing Population
The report titled “Russia Over-the-counter (OTC) Drugs Industry Outlook to 2017- Driven by Rising Ageing Population” presents a comprehensive analysis of the industry covering aspects including market size by revenue and by volume and market segmentation by cold and cough medications, analgesics, digestives, skin treatment products, vitamin and mineral supplements and others. The report also entails a detailed description on the recent trends and developments in the market in and competitive scenario of major players in the industry along with providing market share of major companies in the overall market and market share of major drugs in each category.
The OTC drugs market in Russia has emerged as the fastest growing sectors of the pharmaceutical market in Central and Eastern European region due to its low cost manufacturing. The market has registered a CAGR of 10.3% during 2006-2012 by rising from USD ~ million in 2006 to USD ~ million in 2012.
Cold and cough medications commanded the largest share of ~% share of the total OTC drugs sales in the country in 2012 which has risen from ~% in 2006 followed by Digestives which grew from USD ~ million in 2006 to USD ~ million in 2012. Analgesics have also showcased double digit growth rate in terms of the market revenue and has risen its share from ~% in 2010 to ~% in 2012. Around USD ~ million worth vitamins and minerals were sold in the Russian market in 2012, thereby registering a strong CAGR of 12.9% over the period 2006-2012.
Moscow accounted for the highest share of ~% of the total sales of OTC drugs in Russia in 2012, followed by Saint Petersburg which accounted for ~% of the OTC drugs sales in the country during the year.
Pharmstandard is the largest company with a market share of ~%. The revenue from the sales of OTC drugs by the company was recorded as USD ~ million in 2012 as compared to USD ~ million in 2011. Sanofi Aventis is the second largest OTC drugs company Russia recorded a market share of ~% in 1H2013 followed by Sandoz and Bayer holding nearly ~% in the market.
The anti cold and flu drugs market in Russia was primarily led by aribdol, which was the category leader in anti cold and flu drugs in Russia in 2012 with a market share of ~% followed by Theraflu of Novartis accounting for a share of ~% in the market in 2012. Multivitamins with minerals market in Russia is majorly tapped by Vitrum drug supplied by unipharm with a market share of ~% in 2012.
The future of the Russia OTC drugs industry is expected to be favorable on account of rapidly growing elderly population; rising obesity and a large number of smokers who will contribute to the demand for over the counter drugs in Russia in the future. The market is projected to reach USD ~ million by 2017.
KEY TOPICS COVERED IN THE REPORT
The OTC drugs market in Russia has emerged as the fastest growing sectors of the pharmaceutical market in Central and Eastern European region due to its low cost manufacturing. The market has registered a CAGR of 10.3% during 2006-2012 by rising from USD ~ million in 2006 to USD ~ million in 2012.
Cold and cough medications commanded the largest share of ~% share of the total OTC drugs sales in the country in 2012 which has risen from ~% in 2006 followed by Digestives which grew from USD ~ million in 2006 to USD ~ million in 2012. Analgesics have also showcased double digit growth rate in terms of the market revenue and has risen its share from ~% in 2010 to ~% in 2012. Around USD ~ million worth vitamins and minerals were sold in the Russian market in 2012, thereby registering a strong CAGR of 12.9% over the period 2006-2012.
Moscow accounted for the highest share of ~% of the total sales of OTC drugs in Russia in 2012, followed by Saint Petersburg which accounted for ~% of the OTC drugs sales in the country during the year.
Pharmstandard is the largest company with a market share of ~%. The revenue from the sales of OTC drugs by the company was recorded as USD ~ million in 2012 as compared to USD ~ million in 2011. Sanofi Aventis is the second largest OTC drugs company Russia recorded a market share of ~% in 1H2013 followed by Sandoz and Bayer holding nearly ~% in the market.
The anti cold and flu drugs market in Russia was primarily led by aribdol, which was the category leader in anti cold and flu drugs in Russia in 2012 with a market share of ~% followed by Theraflu of Novartis accounting for a share of ~% in the market in 2012. Multivitamins with minerals market in Russia is majorly tapped by Vitrum drug supplied by unipharm with a market share of ~% in 2012.
The future of the Russia OTC drugs industry is expected to be favorable on account of rapidly growing elderly population; rising obesity and a large number of smokers who will contribute to the demand for over the counter drugs in Russia in the future. The market is projected to reach USD ~ million by 2017.
KEY TOPICS COVERED IN THE REPORT
- Market Size of Russia OTC Drugs Market by Revenue, 2006-2012
- Market Size of Russia OTC Drugs Market by Volume, 2008-2012
- Market Segmentation of Russia OTC Drugs Market by Key Product Categories, 2006-2012
- Market Segmentation of Russia OTC Drugs Market by major City wise sales value, 2012
- Trends and Developments in Russia OTC Drugs Market
- Government Regulations in the OTC Drugs Market in Russia
- Market Share of Major Players in OTC drugs market in Russia
- Market Share of Major brands in key product categories of OTC drugs
- Future Outlook and Projections in Russia OTC Drugs Market
1. CENTRAL AND EASTERN EUROPE OTC DRUGS MARKET INTRODUCTION
1.1. Central and Eastern Europe OTC Drugs Market Size by Revenue, 2006-2012
2. RUSSIA OTC DRUGS MARKET INTRODUCTION
3. RUSSIA OTC DRUGS MARKET SIZE, 2006-2012
3.1. By Revenue, 2006-2012
3.2. By Volume, 2008-2012
4. RUSSIA OTC DRUGS MARKET SEGMENTATION, 2006-2012
4.1. By Cold and Cough, Analgesics, Digestives, Skin Products, Vitamins and Minerals and Others, 2006-2012
4.2. By Cities, 2012
5. TRENDS AND DEVELOPMENTS IN RUSSIA OTC DRUGS MARKET
Approval of Selling of OTC Drugs in retail stores by Ministry of Healthcare
Appointment of New Government: Spurring Developments in Health Sector in Russia
Increasing Focus on Bio-Additives and Functional Nutrition
6. GOVERNMENT REGULATIONS IN RUSSIA OTC DRUGS INDUSTRY
Ban on Over the Counter Sales of Medical Drugs
Major Regulatory Changes in Russian Pharmaceutical Market in 2012
7. MARKET SHARE OF MAJOR PLAYERS IN RUSSIA OTC DRUGS MARKET, 1H2013
7.1. By Anti Cold and Flu Drugs, 2012
7.2. By Non- Narcotic Analgesics and Antipyretic Drugs, 2012
7.3. By Expectorants & Antitussives (Cough Medications), 2012
7.4. By Multivitamins with Minerals, 2012
7.5. By Systematic Agents for Fungal Infections, 2012
8. COMPETITIVE LANDSCAPE OF MAJOR PLAYERS IN RUSSIA OTC DRUGS MARKET
9. RUSSIA OTC DRUGS MARKET FUTURE OUTLOOK AND PROJECTIONS, 2013-2017
10. MACRO ECONOMIC FACTORS OF RUSSIA OTC DRUGS MARKET: HISTORICAL AND PROJECTED
10.1. Population, 2006-2017
10.2. Public and Private Health Expenditure, 2006-2017
10.3. Consumer Price Index on Medicines, 2010-2012
11. APPENDIX
11.1. Market Definitions
11.2. Abbreviations
11.3. Research Methodology
Data Collection Methods
Approach
Variables (Dependent and Independent)
Multi Factor Based Sensitivity Model
Final Conclusion
11.4. Disclaimer
1.1. Central and Eastern Europe OTC Drugs Market Size by Revenue, 2006-2012
2. RUSSIA OTC DRUGS MARKET INTRODUCTION
3. RUSSIA OTC DRUGS MARKET SIZE, 2006-2012
3.1. By Revenue, 2006-2012
3.2. By Volume, 2008-2012
4. RUSSIA OTC DRUGS MARKET SEGMENTATION, 2006-2012
4.1. By Cold and Cough, Analgesics, Digestives, Skin Products, Vitamins and Minerals and Others, 2006-2012
4.2. By Cities, 2012
5. TRENDS AND DEVELOPMENTS IN RUSSIA OTC DRUGS MARKET
Approval of Selling of OTC Drugs in retail stores by Ministry of Healthcare
Appointment of New Government: Spurring Developments in Health Sector in Russia
Increasing Focus on Bio-Additives and Functional Nutrition
6. GOVERNMENT REGULATIONS IN RUSSIA OTC DRUGS INDUSTRY
Ban on Over the Counter Sales of Medical Drugs
Major Regulatory Changes in Russian Pharmaceutical Market in 2012
7. MARKET SHARE OF MAJOR PLAYERS IN RUSSIA OTC DRUGS MARKET, 1H2013
7.1. By Anti Cold and Flu Drugs, 2012
7.2. By Non- Narcotic Analgesics and Antipyretic Drugs, 2012
7.3. By Expectorants & Antitussives (Cough Medications), 2012
7.4. By Multivitamins with Minerals, 2012
7.5. By Systematic Agents for Fungal Infections, 2012
8. COMPETITIVE LANDSCAPE OF MAJOR PLAYERS IN RUSSIA OTC DRUGS MARKET
9. RUSSIA OTC DRUGS MARKET FUTURE OUTLOOK AND PROJECTIONS, 2013-2017
10. MACRO ECONOMIC FACTORS OF RUSSIA OTC DRUGS MARKET: HISTORICAL AND PROJECTED
10.1. Population, 2006-2017
10.2. Public and Private Health Expenditure, 2006-2017
10.3. Consumer Price Index on Medicines, 2010-2012
11. APPENDIX
11.1. Market Definitions
11.2. Abbreviations
11.3. Research Methodology
Data Collection Methods
Approach
Variables (Dependent and Independent)
Multi Factor Based Sensitivity Model
Final Conclusion
11.4. Disclaimer
LIST OF FIGURES
Figure 1: Average Annual Per Capita Expenditure on Non-Prescriptions Drugs by Several Countries in Central and Eastern Europe in USD, 2010-2011
Figure 2: Central and Eastern Europe OTC Drugs Market Size by Revenue in USD Million, 2006-2012
Figure 3: Russia OTC Drugs Market Size by Revenue in USD Million, 2006-2012
Figure 4: Russian OTC Drugs Market Size by Volume Sales in Million Packs, 2008-2012
Figure 5: Market Share of Major Players in Russian OTC Drugs Market in Percentage (%), 1H2013
Figure 6: Market Share of Anti Cold and Flu Drugs in Russia OTC Drugs Market by Name of the Drug and the Company in Percentage (%), 2012
Figure 7: Market Share of Non- Narcotic Analgesics and Antipyretic Drugs in Russia OTC Drugs Market by Name of the Drug and the Company in Percentage (%), 2012
Figure 8: Market Share of Expectorants & Antitussives in Russia OTC Drugs Market by Name of the Drug and the Company in Percentage (%), 2012
Figure 9: Market Share of Multivitamins with Minerals in Russia OTC Drugs Market by Name of the Drug and the Company in Percentage (%), 2012
Figure 10: Market Share of Systematic Agents for Fungal Infections in Russia OTC Drugs Market by Name of the Drug and the Company in Percentage (%), 2012
Figure 11: Russia OTC Drugs Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 12: Population in Russia in Million, 2006-2017
Figure 13: Health Expenditure of Households in Russia in USD Million, 2006-2017
Figure 1: Average Annual Per Capita Expenditure on Non-Prescriptions Drugs by Several Countries in Central and Eastern Europe in USD, 2010-2011
Figure 2: Central and Eastern Europe OTC Drugs Market Size by Revenue in USD Million, 2006-2012
Figure 3: Russia OTC Drugs Market Size by Revenue in USD Million, 2006-2012
Figure 4: Russian OTC Drugs Market Size by Volume Sales in Million Packs, 2008-2012
Figure 5: Market Share of Major Players in Russian OTC Drugs Market in Percentage (%), 1H2013
Figure 6: Market Share of Anti Cold and Flu Drugs in Russia OTC Drugs Market by Name of the Drug and the Company in Percentage (%), 2012
Figure 7: Market Share of Non- Narcotic Analgesics and Antipyretic Drugs in Russia OTC Drugs Market by Name of the Drug and the Company in Percentage (%), 2012
Figure 8: Market Share of Expectorants & Antitussives in Russia OTC Drugs Market by Name of the Drug and the Company in Percentage (%), 2012
Figure 9: Market Share of Multivitamins with Minerals in Russia OTC Drugs Market by Name of the Drug and the Company in Percentage (%), 2012
Figure 10: Market Share of Systematic Agents for Fungal Infections in Russia OTC Drugs Market by Name of the Drug and the Company in Percentage (%), 2012
Figure 11: Russia OTC Drugs Market Future Projections on the Basis of Revenue in USD Million, 2013-2017
Figure 12: Population in Russia in Million, 2006-2017
Figure 13: Health Expenditure of Households in Russia in USD Million, 2006-2017
LIST OF TABLES
Table 1: Russia OTC Drugs Market Segmentation by Cold and Cough, Digestives, Analgesics, Skin Products, Vitamins and Minerals and Others on the Basis of Revenue in USD Million, 2006-2012
Table 2: Number of Deaths in Russia due to Types of Diseases, 2007-2011
Table 3: Russia OTC Drug Sales by Regions on the Basis of Contribution in Percentage (%), 2012
Table 4: Top 10 OTC Drugs Sold by Pharmstandard in Russia by Volume in Million Packs and Sales Value in USD Million, 9M2013
Table 5: Difference between Narcotic and Non-Narcotic Analgesics Available in the Market
Table 6: Dosage of Nurofen for Children by Age, Quantity and Frequency of Dosage in a Day
Table 7: Competitive Landscape of Major Players in OTC Drugs Market in Russia
Table 8: Product Pipeline of Pharmstandard by Product, Group, Therapeutic Segment and Planned Launch, 2013
Table 9: Consumer Price Index on Medicines in Russia, 2010-2012
Table 10: Correlation Matrix of Russia OTC Drugs Industry
Table 11: Regression Coefficients Output of Russia OTC Drugs Market
Table 1: Russia OTC Drugs Market Segmentation by Cold and Cough, Digestives, Analgesics, Skin Products, Vitamins and Minerals and Others on the Basis of Revenue in USD Million, 2006-2012
Table 2: Number of Deaths in Russia due to Types of Diseases, 2007-2011
Table 3: Russia OTC Drug Sales by Regions on the Basis of Contribution in Percentage (%), 2012
Table 4: Top 10 OTC Drugs Sold by Pharmstandard in Russia by Volume in Million Packs and Sales Value in USD Million, 9M2013
Table 5: Difference between Narcotic and Non-Narcotic Analgesics Available in the Market
Table 6: Dosage of Nurofen for Children by Age, Quantity and Frequency of Dosage in a Day
Table 7: Competitive Landscape of Major Players in OTC Drugs Market in Russia
Table 8: Product Pipeline of Pharmstandard by Product, Group, Therapeutic Segment and Planned Launch, 2013
Table 9: Consumer Price Index on Medicines in Russia, 2010-2012
Table 10: Correlation Matrix of Russia OTC Drugs Industry
Table 11: Regression Coefficients Output of Russia OTC Drugs Market
